Infection control guidelines for the cardiac catheterization laboratory: Society guidelines revisited

Catheterization and Cardiovascular Interventions

Volumn 67, Issue 1, 2006, Pages 78-86

  Chambers, Charles E ^a   Eisenhauer, Michael D ^b   McNicol, Lynn B ^b   Block, Peter C ^b   Phillips, William J ^b   Dehmer, Gregory J ^b   Heupler, Frederick A ^b   Blankenship, James C ^b  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^b NONE

Author keywords

Adverse effects; Cardiac catheterization; Coronary intervention; Device infection; Laboratory infection; Quality control

Indexed keywords

ANTIBIOTIC AGENT; CEFAZOLIN; CEPHALOSPORIN DERIVATIVE; CHLORHEXIDINE; CHLORHEXIDINE GLUCONATE; HEPATITIS B VACCINE; IODOPHOR; POVIDONE IODINE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; VANCOMYCIN;

AIR CONDITIONING; ANTIBIOTIC PROPHYLAXIS; ARTERIOTOMY; ARTERITIS; BRACHIAL ARTERY; CORONARY STENT; DEVICE; FOLLOW UP; HAND WASHING; HEART CATHETERIZATION; HUMAN; HYGIENE; IMPLANTATION; INFECTION CONTROL; INFECTION PREVENTION; INFECTION RATE; INSTRUMENT STERILIZATION; LABORATORY PERSONNEL; MEDICAL SOCIETY; PRACTICE GUIDELINE; PREOPERATIVE CARE; PROTECTIVE CLOTHING; QUALITY CONTROL; REVIEW; RISK BENEFIT ANALYSIS; SCREENING; SKIN FLORA; VACCINATION; VASCULAR ACCESS; WASTE DISPOSAL; WOUND DRESSING; WOUND INFECTION;

ANTIBIOTIC PROPHYLAXIS; BANDAGES; CORONARY ANGIOGRAPHY; HAIR REMOVAL; HANDWASHING; HEART CATHETERIZATION; HUMANS; INFECTION CONTROL; QUALITY CONTROL;

EID: 30344454657     PISSN: 15221946     EISSN: None     Source Type: Journal    
DOI: 10.1002/ccd.20589     Document Type: Review

References (34)

1. Heupler FA, Heisler M, Keys TF, et al. Infection prevention guidelines for cardiac catheterization laboratories. Cathet Cardiovasc Diagn 1992;25:260-263.
2. Baddour LM, Bettmann MA, Bolger AF, et al. Nonvalvular cardiovascular device-related infections. Circulation 2003;108:2015-2031.
3. Munoz P, Blanco JR, Rdoriguez-Creixems M, et al. Blood stream infections after invasive nonsurgical cardiology procedures. Arch Intern Med 2001;161:2110-2115.
4. Samore MH, Wessolossky MA, Lewis SM, et al. Frequency, risk factors, and outcome for bacteremia after percutaneous transluminal coronary angioplasty. Am J Cardiol 1997;79:873-877.
5. Ramsdale D, Aziz S, Newall N, et al. Bacteremia following complex percutaneous coronary intervention. J Invas Cardiol 2004;16:632-634.
6. Bouchart F, Dubar A, Bessou JP, et al. Pseudomonas aeruginosa coronary stent infection. Ann Thorac Surg 1997;64:1810-1813.
7. Carey D, Martin JR, Moore CA, et al. Complications of femoral artery closure devices. Catheter Cardiovasc Interv 2001;52:3-8.
8. Department of Labor, Occupational Safety and Health Administration. Occupational exposure to blood borne pathogens: final rule. Fed Reg 1991;56:64004-64182.
9. O'Grady NP, Alexander M, Dellinger EP, et al. Guidelines for the prevention of intravascular catheter-related infections. Centers for Disease Control and Prevention. MMWR Recomm Rep 2002;51(RR-10):1-29.
10. Mangram AJ, Horan TC, Pearson ML, et al. Guideline for the prevention of surgical site infection, 1999. Infect Control Hosp Epidemiol 1999;20:247-280.
11. Bratzler DW, Houck PM. Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project. Clin Infect Dis 2004;38:1706-1715.
12. Boyce JM, Pittet D, et al. Guideline for hand hygiene in health-care settings. Recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. Society for Healthcare Epidemiology of America/Association for Professionals in Infection Control/Infectious Diseases Society of America. MMWR Recomm Rep 2002;51(RR-16):1-45.
13. Sehulster L, Chinn RY. CDC; HICPAC. Guidelines for environmental infection control in health-care facilities. Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee (HICPAC). MMWR Recomm Rep 2003;52(RR-10):1-42.
14. Alexander JW, Fischer JE, Boyajian M, et al. The influence of hair-removal methods on wound infections. Arch Surg 1983;118:347-352.
15. Center for Infectious Diseases, Centers for Disease Control, Public Health Service, U.S. Department of Health and Human Services. Guideline for prevention of surgical wound infections, 1985, revised by Garner JS. Atlanta, GA: U.S. Department of Health and Human Services.
16. Lazenby KW, Zelano JA, Isom OW, et al. Effects of shaving methods and intraoperative irrigation on suppurative mediastinitis after bypass operation. Ann Thorac Surg 1991;53:301-305.
17. Olson MM, MacCallum J, McQuarrie DG. Preoperative hair removal with clippers does not increase infection rate in clean surgical wounds. Surg Gynecol Obstet 1986;162:181-182.
18. Rutala WA. APIC guidelines for infection control practice: APIC guideline for selection and use of disinfectants. Am J Infect Control 1996;24:313-342.
19. Medical Letter on Drugs and Therapeutics. Antimicrobial prophylaxis in surgery. Med Lett 1989;12:105-108.
20. Dellinger EP, Gross PA, Barrett TL, et al. Quality standard for antimicrobial prophylaxis in surgical procedures. Clin Infect Dis 1994;18:422-427.
21. Wiener RS, Ong LS. Local infection after percutaneous transluminal coronary angioplasty: relation to early repuncture of ipsilateral femoral artery. Cathet Cardiovasc Diagn 1989;16:180-181.
22. Polanczyk CA, Rohde LE, Goldman L. Right heart catheterization and cardiac complications in patients undergoing noncardiac surgery: an observational study. JAMA 2001;286:309-314.
23. Toursarkissian B, Mejia A, Smilanich RP, Shireman PK, Sykes MT. Changing patterns of access site complications with the use of percutaneous closure devices. Vasc Surg 2001;35:203-206.
24. Samal AK, White CJ. Percutaneous management of access site complications. Catheter Cardiovasc Interv 2002;57:12-23.
25. Cooper CL, Miller A. Infectious complications related to the use of the angio-seal hemostatic puncture closure device. Catheter Cardiovasc Interv 1999;48:301-303.
26. Corona ML, Peters SG, Narr BJ, et al. Subspecialty clinics: critical-care medicine. Mayo Clin Proc 1990;65:979-986.
27. Larson E. APIC guidelines for infection control practice: guideline for use of topical antimicrobial agents. Mundelein, IL: APIC National Office.
28. Palmisano JM, Meliones JN. Damage to physicians' gloves during "routine" cardiac catheterization: an underappreciated occurrence. J Am Coll Cardiol 1989;14:1527-1529.
29. Laslett LJ, Sabin A. Wearing of caps and masks not necessary during cardiac catheterization. Cathet Cardiovasc Diagn 1989;17:158-169.
30. Banai S, Selitser V, Keren A, et al. Prospective study of bacteremia after cardiac catheterization. Am J Cardiol 2003;92:1004-1007.
31. Gerberding J, Littell C, Tarkington A, et al. Risk of exposure of surgical personnel to patients' blood during surgery at San Francisco General Hospital. N Engl J Med 1990;322:1788-1793.
32. U.S. Public Health Service. Updated U.S. Public Health Service Guidelines for the Management of Occupational Exposures to HBV, HCV, and HIV and Recommendations for Postexposure Prophylaxis. MMWR Recomm Rep. 2001;50(RR-11):1-52.
33. Protection against viral hepatitis. Recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR Recomm Rep 1990;39(RR-2):1-26.
34. Feigal DW. Reprocessing of single-use devices: letter in attachment on reprocessing of single use medical devices by hospitals, from Center for Devices and Radiologic Health, U.S. Food and Drug Administration. Infect Control Hosp Epidemiol 2000;21:801-804.